Series location:
Virtual during COVID pandemic
Washington, DC
United States
See map: Google Maps
Friday at 8:00 AM
For questions, contact Dorothy Martinez
| Session |
Date |
|---|---|
| AML: An Overview Regarding Induction and Consolidation Options | 02/21/2025 - 8:00am to 9:00am EST |
| Expert Perspectives on Emerging Data and Evolving Therapies in R/R PTCL | 02/14/2025 - 8:00am to 9:00am EST |
| Improving Therapeutic Approaches in SCLC & Advancing the Art of Building Phase 1 Program | 02/07/2025 - 8:00am to 9:00am EST |
| Redefining Treatment Across the Spectrum of HR+ HER2-Expressing Metastatic Breast Cancer | 01/24/2025 - 8:00am to 9:00am EST |
| Case of Metastatic HER2+ NSCLC | 01/24/2025 - 8:00am to 9:00am EST |
| Novel Treatments for Newly Diagnosed Ph+CML-CP: Striking the Balance of Treatment with Patient Goals and QoL | 01/17/2025 - 8:00am to 9:00am EST |
| Case of Hodgkin’s Lymphoma | 01/10/2025 - 8:00am to 9:00am EST |
| ASH 2024 Updates | 12/20/2024 - 8:08am to 9:00am EST |
| Reviving the BTK Target in MCL: Recalibrating the Treatment Sequence With Non-Covalent BTK Inhibitors in R/R Disease | 12/13/2024 - 8:00am to 9:00am EST |
| Biomaker Testing in NSCLC | 12/06/2024 - 8:00am to 9:00am EST |